Literature DB >> 17157171

Tissue distribution of endothelial cells in vivo following intravenous injection.

Bruno Larrivée1, Peggy L Olive, Aly Karsan.   

Abstract

OBJECTIVE: Recent studies have suggested that endothelial cells derived from circulating endothelial progenitors can be used as carriers for cell-based therapy. However, the in vivo homing properties of mature endothelial cells are still unclear. In this paper, we studied the kinetics and specificity of endothelial homing to sites of angiogenesis.
METHODS: The kinetics of the distribution of endothelial cells in mice following intravenous injection of 3H-thymidine-labeled microvascular endothelial cells were examined. To detect the homing of viable and apoptotic endothelial cells, GFP-labeled microvascular endothelial cells were injected intravenously in immunodeficient mice.
RESULTS: We observed that endothelial cells injected intravenously transit rapidly through the lungs, but do not home specifically to any organ. We did not observe specific accumulation of endothelial cells in subcutaneously implanted tumors following intravenous injection. Rare GFP-labeled endothelial cells were observed in the proximity of tumor blood vessels. However, similar findings were seen when GFP-labeled apoptotic endothelial cells were injected intravenously.
CONCLUSION: These findings suggest that integration of mature endothelial cells to the vasculature is a rare event and that engulfment of apoptotic bodies, independent of nuclear fusion, may be misinterpreted as cell plasticity, and care should be taken in the interpretation of such findings.

Entities:  

Mesh:

Year:  2006        PMID: 17157171     DOI: 10.1016/j.exphem.2006.08.006

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  1 in total

1.  Placental growth factor expression is required for bone marrow endothelial cell support of primitive murine hematopoietic cells.

Authors:  Xiaoying Zhou; Lora W Barsky; Gregor B Adams
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.